News & opinion
Patent descriptions: T1742/19 and insufficient disclosure
A November 2022 decision by the Boards of Appeal of the European Patent Office addresses several issues relating to the sufficiency of disclosure in patent descriptions.
Keep up to date by subscribing to our newsletter Perspectives.
A November 2022 decision by the Boards of Appeal of the European Patent Office addresses several issues relating to the sufficiency of disclosure in patent descriptions.
When seeking to describe a particular characteristic, intended purpose or function of a product, you can reference another brand’s trademark. However, there can be a fine line between such informative use and trademark infringement.
In our 7 March webinar on IP and packaging, our experts explained how to use trademarks, designs and copyright to protect packaging visuals and messaging, and tackle IP infringement and counterfeiting.
A thorough review of your trademark portfolio now will put both your IP rights and your business in a strong position for the year to come. Assess your registrations for strength, accuracy and cost with the help of our three-step process.
Yet another country has deposited its instrument of accession to the Madrid System for international trademark registrations, with Belize joining the list of Madrid System countries as of 24 February 2023.
With the imminent entry into force of the Unified Patent Court Agreement, the countdown has begun to opt-out of the jurisdiction of the new European court. Marie-Noëlle de la Fouchardière explains what can be opted out, by whom and how to simplify the management of opt-out declarations.
In November 2022, the European Commission published a proposal to update current EU design law to adapt it to the digital age. Noa Rubingh outlines the proposed changes and the road to implementation.
A recent finding of invalidity against sports brand Puma provides a valuable reminder of the need to obtain design registration within the designated 12-month grace period – and to be careful of accidental publication online.
Whether you choose to file a patent application or keep a new invention secret, it’s crucial to take steps to minimise the risks of disclosure. Rose-Marie Ehanno explains how to keep patentable inventions confidential.
When deciding on your IP enforcement and protection strategy, both the 'sword' and 'shield' functions of trademarks must be kept in mind, says Laura Morrish.
Must a compound be shown to be suitable for each disease for first medical use claims to be sufficiently disclosed in applications for European patents, asks Matthieu Boulard.
The short answer is ‘yes’, you can own a fictional character, says UK Trademark Attorney Luke Portnow, and this summer the UK saw a particularly interesting case law development in copyright protection.